Ju Hee Lee

Title: Ju Hee Lee: Innovator in PDE9A Inhibitory Compounds

Introduction

Ju Hee Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that exhibit PDE9A inhibitory activity. His work is crucial for advancing treatments for diseases related to this enzyme.

Latest Patents

Ju Hee Lee holds 2 patents related to his innovative work. His latest patents focus on compounds that have a specific chemical structure and demonstrate PDE9A inhibitory activity. These patents provide compositions containing these compounds or their pharmaceutically acceptable salts. Furthermore, they outline pharmaceutical uses for treating or preventing PDE9A-related diseases. The methods described involve administering effective amounts of these compounds or compositions to subjects in need of treatment.

Career Highlights

Ju Hee Lee is affiliated with the Korea Research Institute of Chemical Technology. His research has been instrumental in exploring new therapeutic avenues for PDE9A-related conditions. His dedication to innovation in pharmaceutical applications has positioned him as a key figure in his field.

Collaborations

Ju Hee Lee has collaborated with notable colleagues, including Chae Jo Lim and Kwang-Seok Oh. These partnerships have enhanced the scope and impact of his research endeavors.

Conclusion

Ju Hee Lee's contributions to the development of PDE9A inhibitory compounds represent a significant advancement in pharmaceutical science. His work continues to pave the way for new treatments that could benefit many patients.